Cite
HARVARD Citation
Prosperini, L. et al. (2015). Sustained disability improvement is associated with T1 lesion volume shrinkage in natalizumab-treated patients with multiple sclerosis. Journal of neurology, neurosurgery and psychiatry. 86 (2), pp. 236-238. [Online].